Science
FDA Rejects Summit’s Ivonescimab Lung Cancer Drug Over Survival Data
The FDA has declined to approve ivonescimab, a lung cancer drug developed in China, after its global trial slowed tumours…
The FDA has declined to approve ivonescimab, a lung cancer drug developed in China, after its global trial slowed tumours…